BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 15474705)

  • 1. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.
    Mattion N; König G; Seki C; Smitsaart E; Maradei E; Robiolo B; Duffy S; León E; Piccone M; Sadir A; Bottini R; Cosentino B; Falczuk A; Maresca R; Periolo O; Bellinzoni R; Espinoza A; Torre JL; Palma EL
    Vaccine; 2004 Oct; 22(31-32):4149-62. PubMed ID: 15474705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies.
    Seki C; Robiolo B; Periolo O; Iglesias M; D'Antuono A; Maradei E; Barros V; La Torre J; Mattion N
    Vet Microbiol; 2009 Jan; 133(3):239-51. PubMed ID: 18774662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina.
    Maradei E; La Torre J; Robiolo B; Esteves J; Seki C; Pedemonte A; Iglesias M; D'Aloia R; Mattion N
    Vaccine; 2008 Dec; 26(51):6577-86. PubMed ID: 18835312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests.
    Robiolo B; Seki C; Fondevilla N; Grigera P; Scodeller E; Periolo O; La Torre J; Mattion N
    Vaccine; 2006 Feb; 24(7):997-1008. PubMed ID: 16171905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of foot-and-mouth disease virus types A and O isolated in Argentina during the 2000-2002 epizootic.
    König GA; Palma EL; Maradei E; Piccone ME
    Vet Microbiol; 2007 Sep; 124(1-2):1-15. PubMed ID: 17475419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region.
    Maradei E; Perez Beascoechea C; Malirat V; Salgado G; Seki C; Pedemonte A; Bonastre P; D'Aloia R; La Torre JL; Mattion N; Rodríguez Toledo J; Bergmann IE
    Vaccine; 2011 Oct; 29(46):8230-40. PubMed ID: 21911020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic and genetic analyses of foot-and-mouth disease virus type A isolates for selection of candidate vaccine strain reveals emergence of a variant virus that is responsible for most recent outbreaks in India.
    Jangra RK; Tosh C; Sanyal A; Hemadri D; Bandyopadhyay SK
    Virus Res; 2005 Sep; 112(1-2):52-9. PubMed ID: 16022900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and antigenic site analysis of foot-and-mouth disease virus from pigs and cattle in Korea.
    Oem JK; Lee KN; Cho IS; Kye SJ; Park JY; Park JH; Kim YJ; Joo YS; Song HJ
    J Vet Sci; 2005 Jun; 6(2):117-24. PubMed ID: 15933431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular characterization of aphthous fever virus isolated during the years 1993-1994 in Argentina].
    König G; Blanco C; Feigelstock D; Chimeno Zoth S; Pereda A; Palma EL; Maradei E; Piccone ME
    Rev Argent Microbiol; 2001; 33(2):81-8. PubMed ID: 11494760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology.
    Mattion N; Goris N; Willems T; Robiolo B; Maradei E; Beascoechea CP; Perez A; Smitsaart E; Fondevila N; Palma E; De Clercq K; La Torre J
    Vaccine; 2009 Jan; 27(5):741-7. PubMed ID: 19041355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of foot and mouth disease vaccine strains--a review.
    Paton DJ; Valarcher JF; Bergmann I; Matlho OG; Zakharov VM; Palma EL; Thomson GR
    Rev Sci Tech; 2005 Dec; 24(3):981-93. PubMed ID: 16642769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and antigenic analysis of type A foot-and-mouth disease viruses isolated in India during 1987-1996.
    Nayak B; Pattnaik B; Tosh C; Sanyal A; Hemadri D; Patil SS; Venkataramanan R
    Acta Virol; 2001 Feb; 45(1):13-21. PubMed ID: 11394573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of suitability of two serotype A candidate vaccine strains for inclusion in FMD vaccine in India.
    Mohapatra JK; Hemadri D; Rao TV; Sreenivasa BP; Subramaniam S; Sanyal A; Periyasamy TR; Singh NK; Pattnaik B; Venkataramanan R
    Vet Microbiol; 2008 Sep; 131(1-2):65-72. PubMed ID: 18394827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotype-independent detection of foot-and-mouth disease virus.
    Muller JD; McEachern JA; Bossart KN; Hansson E; Yu M; Clavijo A; Hammond JM; Wang LF
    J Virol Methods; 2008 Jul; 151(1):146-53. PubMed ID: 18440078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-capsid proteins to identify foot-and-mouth disease viral circulation in cattle irrespective of vaccination.
    Bergmann IE; Malirat V; Neitzert E
    Biologicals; 2005 Dec; 33(4):235-9. PubMed ID: 16257539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular epidemiology of foot-and-mouth disease virus serotypes A and O from 1998 to 2004 in Turkey.
    Klein J; Parlak U; Ozyörük F; Christensen LS
    BMC Vet Res; 2006 Dec; 2():35. PubMed ID: 17144917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
    Brehm KE; Kumar N; Thulke HH; Haas B
    Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.